Hikma Pharmaceuticals Plc Director/PDMR Shareholding
13 8월 2024 - 5:39PM
RNS Regulatory News
RNS Number : 2589A
Hikma Pharmaceuticals Plc
13 August 2024
Hikma Pharmaceuticals
PLC
(the
"Company")
LONDON, 13 August 2024:
Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai:
HIK) (LEI: 549300BNS685UXH4JI75) announces
it has been notified of the following transaction by a Person
Discharging Managerial Responsibilities ("PDMR") of the Company.
This notification is made under
Article 19(1) of the EU Market Abuse Regulation 596/2014 as it
forms part of domestic law by virtue of the European Union
(Withdrawal) Act 2018 ("MAR"). The
information set out below is provided in accordance with the
requirements of Article 19(3) of MAR.
Notification and public
disclosure of transactions by A Person Discharging Managerial
Responsibilities
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Bassam Kanaan
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
PDMR
|
|
b)
|
Initial notification
/Amendment
|
Initial notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Hikma Pharmaceuticals PLC
|
|
b)
|
LEI
|
549300BNS685UXH4JI75
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument and identification code
|
Description: Ordinary shares of 10
pence each (Shares)
ID Code: GB00B0LCW083
|
|
b)
|
Nature of the transaction
|
Disposal of Shares in Hikma
Pharmaceuticals PLC
|
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
£19.60
|
35,000
|
|
d)
|
Aggregated information
|
Price(s): £19.60
Volume(s): 35,000
Total: £686,000
|
|
e)
|
Date of the transaction
|
8 August 2024
|
|
f)
|
Place of the transaction
|
London Stock Exchange
(XLON)
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument and identification code
|
Description: Ordinary shares of 10
pence each (Shares)
ID Code: GB00B0LCW083
|
|
b)
|
Nature of the transaction
|
Disposal of Shares in Hikma
Pharmaceuticals PLC
|
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
£20.25
|
10,000
|
|
d)
|
Aggregated information
|
Price(s): £20.25
Volume(s): 10,000
Total: £202,500
|
|
e)
|
Date of the transaction
|
9 August 2024
|
|
f)
|
Place of the transaction
|
London Stock Exchange
(XLON)
|
Helen Middlemist
Group Company Secretary
+44 (0) 20 7399 2760
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
DSHGIGDIIXBDGSX
Hikma Pharmaceuticals (LSE:HIK)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
Hikma Pharmaceuticals (LSE:HIK)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024
